Subscribe
24 Oct 2024 11:22 AM
In conversation with Bhavna Kewalramani, Sanofi India and Atul Suri, Alembic Pharmaceuticals.
30 Oct 2025 1:29 PM
30 Oct 2025 11:33 AM
30 Oct 2025 11:18 AM
30 Oct 2025 9:20 AM
30 Sep 2025 5:25 AM
29 Sep 2025 10:42 AM
26 Sep 2025 10:29 AM
23 Sep 2025 4:01 PM